Tech Company Financing Transactions
Cytogel Pharma Funding Round
On 7/14/2013, Cytogel Pharma announced $750 thousand in funding from private investors.
Transaction Overview
Company Name
Announced On
7/14/2013
Transaction Type
Debt
Amount
$750,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 Thorndal Cir.
Darien, CT 06820
USA
Darien, CT 06820
USA
Phone
Website
Email Address
Overview
Cytogel Pharma is a bio-pharmaceutical development company that pursues strategic opportunities for pharmaceutical product development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dean Maglaris
Chief Scientific Officer
Theodore Maione
VP - Bus. Development
James Hamsher
Browse more venture capital transactions:
Prev: 7/13/2013: Drip Drop venture capital transaction
Next: 7/14/2013: Vascular Therapies venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs